Abstract
Introduction and hypothesis
Mixed urinary incontinence (MUI), defined as mixed symptoms of stress urinary incontinence (SUI) and overactive bladder (OAB), is a difficult entity if conservative treatment has failed. Cure rates are low compared with SUI, particularly the OAB component, may deteriorate after sling insertion. Bulking agents pose an appealing alternative for the treatment of MUI. They have shown beneficial effect in small case studies, but larger series are lacking. The aim of this prospective study was an analysis of treatment efficacy and safety profile of the bulking agent, Bulkamid, in female patients with MUI.
Methods
One hundred fifty-four women with MUI symptoms (components of SUI/OAB within the limits of 60–40% either way) received bulking therapy with polyacrylamide hydrogel (Bulkamid). Patients were followed-up 3 months postoperatively. Primary outcome was the domain Incontinence impact on the King’s Health Questionnaire (KHQ). Secondary outcomes were the other KHQ domains, visual analog scale (VAS), and International Continence Society (ICS) standardized pad weight test as objective measurement of incontinence.
Results
Statistically significant improvements were found for all KHQ domains, pad weight test, and the visual analog scale (VAS) before and after bulking. Overall complication rate was 13%.
Conclusions
This study has shown improvement in MUI after bulking therapy according to both subjective and objective outcomes. We can advocate bulking therapy for treating MUI, as it is simple and safe and shows both objective and subjective improvement and relief. Long-term results (up to 1 year) are awaited.
Similar content being viewed by others
References
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26. doi:10.1007/s00192-009-0976-9.
Myers DL. Female mixed urinary incontinence: a clinical review. JAMA. 2014;311:2007–14. doi:10.1001/jama.2014.4299.
Bandukwala NQ, Gousse AE. Mixed urinary incontinence: what first? Curr Urol Rep. 2015;16:9. doi:10.1007/s11934-015-0483-0.
Kammerer-Doak D, Rizk DE, Sorinola O, Agur W, Ismail S, Bazi T. Mixed urinary incontinence: international urogynecological association research and development committee opinion. Int Urogynecol J. 2014;25:1303–12. doi:10.1007/s00192-014-2485-8.
Rachaneni S, Latthe P. Does preoperative urodynamics improve outcomes for women undergoing surgery for stress urinary incontinence? A systematic review and meta-analysis. BJOG. 2015;122:8–16. doi:10.1111/1471-0528.12954.
Lapitan MC, Cody JD. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2016;2:CD002912. doi:10.1002/14651858.CD002912.pub6.
Wood LN, Anger JT. Urinary incontinence in women. BMJ. 2014;349:g4531.
Abdel-Fattah M, Hopper LR, Mostafa A. Evaluation of transobturator tension-free vaginal tapes in the surgical management of mixed urinary incontinence: 3-year outcomes of a randomized controlled trial. J Urol. 2014;191:114–9. doi:10.1016/j.juro.2013.07.035.
Aigmueller T, Bjelic-Radisic V, Kargl J, Hinterholzer S, Laky R, Trutnovsky G, Kolovetsiou-Kreiner V, Tamussino K. Reasons for dissatisfaction ten years after TVT procedure. Int Urogynecol J. 2014;25:213–7. doi:10.1007/s00192-013-2213-9.
Mohr S, Siegenthaler M, Mueller MD, Kuhn A. Bulking agents: an analysis of 500 cases and review of the literature. Int Urogynecol J. 2013;24:241–7. doi:10.1007/s00192-012-1834-8.
Toozs-Hobson P, Al-Singary W, Fynes M, Tegerstedt G, Lose G. Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid(R)) for female stress and stress-predominant mixed incontinence. Int Urogynecol J. 2012;23:1373–8. doi:10.1007/s00192-012-1761-8.
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104:1374–9.
Bjelic-Radisic V, Dorfer M, Tamussino K, Greimel E. Psychometric properties and validation of the German-language King’s health questionnaire in women with stress urinary incontinence. Neurourol Urodyn. 2005;24:63–8. doi:10.1002/nau.20092.
Zhang XH, Xie F, Wee HL, Thumboo J, Li SC. Applying the expectancy-value model to understand health values. Value Health. 2008;11(Suppl 1):S61–8. doi:10.1111/j.1524-4733.2008.00368.x.
Ryhammer AM, Djurhuus JC, Laurberg S. Pad testing in incontinent women: a review. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10:111–5.
Mouritsen L, Lose G, Moller-Bek K. Long-term follow-up after urethral injection with polyacrylamide hydrogel for female stress incontinence. Acta Obstet Gynecol Scand. 2014;93:209–12. doi:10.1111/aogs.12283.
Leone Roberti MU, Bogani G, Meschia M, Sorice P, Braga A, Salvatore S, Ghezzi F, Serati M. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015;189:48–54. doi:10.1016/j.ejogrb.2015.03.025.
Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2012;CD003881.doi:10.1002/14651858.CD003881.pub3.
Pai A, Al-Singary W. Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid((R))) in the management of stress and mixed urinary incontinence: three year follow up outcomes. Cent Eur J Urol. 2015;68:428–33. doi:10.5173/ceju.2015.647.
Kasi AD, Pergialiotis V, Perrea DN, Khunda A, Doumouchtsis SK. Polyacrylamide hydrogel (Bulkamid(R)) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J. 2016;27:367–75. doi:10.1007/s00192-015-2781-y.
Sokol ER, Karram MM, Dmochowski R. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter north American study. J Urol. 2014;192:843–9. doi:10.1016/j.juro.2014.03.109.
MacLachlan LS, Rovner ES. Management of failed stress urinary incontinence surgery. Curr Urol Rep. 2014;15:429. doi:10.1007/s11934-014-0429-y.
Zimmern PE, Gormley EA, Stoddard AM, Lukacz ES, Sirls L, Brubaker L, Norton P, Oliphant SS, Wilson T. Management of recurrent stress urinary incontinence after burch and sling procedures. Neurourol Urodyn. 2016;35:344–8. doi:10.1002/nau.22714.
Martan A, Masata J, Svabik K, Krhut J. Transurethral injection of polyacrylamide hydrogel (Bulkamid((R))) for the treatment of female stress or mixed urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2014;178:199–202. doi:10.1016/j.ejogrb.2014.03.033.
Zivanovic I, Rautenberg O, Lobodasch K, von Bünau G, Walser C, Viereck V. Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure. Neurourol Urodyn. 2016; doi:10.1002/nau.23007.
Gaddi A, Guaderrama N, Bassiouni N, Bebchuk J, Whitcomb EL. Repeat midurethral sling compared with urethral bulking for recurrent stress urinary incontinence. Obstet Gynecol. 2014;123:1207–12. doi:10.1097/AOG.0000000000000282.
Kunkle CM, Hallock JL, Hu X, Blomquist J, Thung SF, Werner EF. Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2015;21:154–9. doi:10.1097/SPV.0000000000000173.
Krhut J, Martan A, Jurakova M, Nemec D, Masata J, Zvara P. Treatment of stress urinary incontinence using polyacrylamide hydrogel in women after radiotherapy: 1-year follow-up. Int Urogynecol J. 2016;27:301–5. doi:10.1007/s00192-015-2834-2.
Petros PE. Mixed urinary incontinence--time to uncouple urgency from stress? Int Urogynecol J. 2011;22:919–21. doi:10.1007/s00192-011-1449-5.
Kotb AF, Campeau L, Corcos J. Urethral bulking agents: techniques and outcomes. Curr Urol Rep. 2009;10:396–400.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Electronic supplementary material
ESM 1
(JPEG 513 kb)
Rights and permissions
About this article
Cite this article
Mohr, S., Marthaler, C., Imboden, S. et al. Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?. Int Urogynecol J 28, 1657–1661 (2017). https://doi.org/10.1007/s00192-017-3332-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-017-3332-5